Results for "" US-Israeli VC firm NFX launches new Biotech fund NFX launches NFX Bio: a new investment arm that will finance pre-seed and Seed rounds of Israeli and American biotech companies... Yaneev Avital / 3 Feb 2021 • 1 min read NFX, an Israeli-American venture capital firm that focuses on pre-seed and Seed investments, announced the launch of NFX Bio - the new investment arm led by Venture Partner Dr. Omri Amirav Drory. Founder and CEO of Twist Bioscience, Emily Leproust Ph.D., will join the NFX Bio team as an advisor. Synthetic DNA funding According to the VC fund’s announcement, NFX Bio will continue the pre-seed and Seed investment focus. Although just recently announced, the fund has already invested in a number of companies, including Twist Bioscience - a synthetic DNA producer founded in 2013, and is currently traded at $8.5 billion; and Mammoth Bioscience, a CRISPR platform founded by Trevor Martin and Jennifer Doudna - a CRISPR pioneer and Noble award winner, who also received funding from British GKS.